Found: 98
Select item for more details and to access through your institution.
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 5, p. 639, doi. 10.1164/rccm.202310-1887OC
- By:
- Publication type:
- Article
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases.
- Published in:
- Respirology, 2022, v. 27, n. 4, p. 294, doi. 10.1111/resp.14231
- By:
- Publication type:
- Article
Idiopathic non-specific interstitial pneumonia.
- Published in:
- Respirology, 2016, v. 21, n. 2, p. 259, doi. 10.1111/resp.12674
- By:
- Publication type:
- Article
B7H3-dependent myeloid-derived suppressor cell recruitment and activation in pulmonary fibrosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.901349
- By:
- Publication type:
- Article
Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2014, v. 50, n. 5, p. 985, doi. 10.1165/rcmb.2013-0342OC
- By:
- Publication type:
- Article
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 4, p. 424, doi. 10.1164/rccm.202403-0636OC
- By:
- Publication type:
- Article
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1121, doi. 10.1164/rccm.202307-1191OC
- By:
- Publication type:
- Article
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1111, doi. 10.1164/rccm.202301-0117OC
- By:
- Publication type:
- Article
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 6, p. 647, doi. 10.1164/rccm.202312-2213SO
- By:
- Publication type:
- Article
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 4, p. 362, doi. 10.1164/rccm.202307-1154WS
- By:
- Publication type:
- Article
Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 8, p. 1156, doi. 10.1513/AnnalsATS.202309-797OC
- By:
- Publication type:
- Article
Deep Learning--based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography Pattern.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 2, p. 218, doi. 10.1513/AnnalsATS.202301-084OC
- By:
- Publication type:
- Article
The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2022, v. 19, n. 12, p. 2003, doi. 10.1513/AnnalsATS.202203-267OC
- By:
- Publication type:
- Article
Hypothyroidism Is Associated with Increased Mortality in Interstitial Pneumonia with Autoimmune Features.
- Published in:
- 2022
- By:
- Publication type:
- letter
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey.
- Published in:
- Annals of the American Thoracic Society, 2022, v. 19, n. 1, p. 66, doi. 10.1513/AnnalsATS.202011-1421OC
- By:
- Publication type:
- Article
Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reply: Improving Care for Patients with Interstitial Lung Disease, Using Machine Learning, Requires Transparency and Reproducibility.
- Published in:
- 2017
- By:
- Publication type:
- letter
Improving Care for Patients with Interstitial Lung Disease Using Machine Learning Requires Transparency and Reproducibility.
- Published in:
- 2017
- By:
- Publication type:
- letter
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Open-access biorepository for idiopathic pulmonary fibrosis. The way forward.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Open-Access Biorepository for Idiopathic Pulmonary Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2014, v. 11, n. 8, p. 1171, doi. 10.1513/AnnalsATS.201406-289OI
- By:
- Publication type:
- Article
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 12, p. 5536, doi. 10.1007/s12325-023-02668-x
- By:
- Publication type:
- Article
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-022-02292-3
- By:
- Publication type:
- Article
Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 6, p. 1039, doi. 10.1002/art.42075
- By:
- Publication type:
- Article
Systemic Sclerosis–Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration–Approved Therapies in Clinical Practice.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 1, p. 13, doi. 10.1002/art.41933
- By:
- Publication type:
- Article
The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Annals of Internal Medicine, 2005, v. 142, n. 12, p. 963
- By:
- Publication type:
- Article
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial.
- Published in:
- BMC Pulmonary Medicine, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12890-022-02281-8
- By:
- Publication type:
- Article
Identification of a unique temporal signature in blood and BAL associated with IPF progression.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67956-w
- By:
- Publication type:
- Article
A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021253
- By:
- Publication type:
- Article
B7H3 expression and significance in idiopathic pulmonary fibrosis.
- Published in:
- Journal of Pathology, 2022, v. 256, n. 3, p. 310, doi. 10.1002/path.5838
- By:
- Publication type:
- Article
Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hospitalizations in patients with idiopathic pulmonary fibrosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.
- Published in:
- Scientific Reports, 2017, p. 46860, doi. 10.1038/srep46860
- By:
- Publication type:
- Article
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.
- Published in:
- Scientific Reports, 2017, p. 46560, doi. 10.1038/srep46560
- By:
- Publication type:
- Article
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 57, p. 1, doi. 10.1126/scitranslmed.3001510
- By:
- Publication type:
- Article
Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
- Published in:
- 2022
- By:
- Publication type:
- letter
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement: Executive Summary.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 4, p. 379, doi. 10.1164/rccm.202206-1041ST
- By:
- Publication type:
- Article
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary Fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- letter
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 9, p. 1084, doi. 10.1164/rccm.202106-1485OC
- By:
- Publication type:
- Article
Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- letter
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity.
- Published in:
- 2019
- By:
- Publication type:
- letter
Patient Registries in Idiopathic Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.
- Published in:
- 2019
- By:
- Publication type:
- editorial
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
- Published in:
- 2018
- By:
- Publication type:
- journal article